Position in GH
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$9,099,738
-$288,357 QoQ
Shares Held
98,514
+7.2% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $14,887,875 across 2 Diagnostics & Research names. GH ranks #1 (61.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
This page
|
98,514 | $9,099,738 | |
| 2 | VCYT |
Veracyte, Inc.
|
179,700 | $5,788,137 |
All Filings in GH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,099,738 | 98,514 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,388,095 | 91,914 | Shares | Sole | 2026-02-12 | |
| 2021-09-30 | $527,292 | 4,218 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $580,339 | 4,673 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,555,808 | 10,192 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $2,426,166 | 18,825 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||